Hematology
Apheresis temporarily lowers viremia in patients with chronic hepatitis C
Published in Hepatitis Weekly, February 23rd, 2004
"Granulocytes and monocytes/macrophages (GM) are known to constitute extra-hepatic sites for hepatitis C virus (HCV) replication and dissemination. Accordingly, we thought that selective GM adsorptive apheresis (GMA) might contribute to the treatment of HCV in patients with high viremia (HCV-RNA >100 kIU/mL). Of six patients (three males and three females), mean age 62.2 years, five had not responded to interferon-alpha (INF-alpha) and one was INF-alpha naive," scientists in Japan report.
"Each patient received five GMA sessions, once a week for 5 weeks. The two antecubital...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-02-23)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Consensus interferon beats out interferon-ribavirin regimens in HCV relapsers - Enzymology
Guanosine assays can estimate the plasma biomarker guanine deaminase - HIV/AIDS Coinfection
High rate of multiple viral infections in Argentina IDUs - HIV/AIDS Therapy
Company ends amdoxovir collaboration - HIV/HCV Coinfection
Risk factors for severe liver fibrosis identified - Hepatitis A Vaccine
Hepatitis A vaccine provides immune memory 12 years after primary course - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
